GovTribe
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Contract Awards
Help
Delivery Order HHSO100201300009I-HHSO10033001T
Award Date
9/16/13
Potential Completion Date
9/8/18
Potential Value
$63M
Overview
Buyer Personas
Industry Personas
Buyer Personas In this Market
2
Activity
2
Transactions
2
Subawards
8
Opportunity Stack
1
Similar Awards
Federal Agency
Office of the Assistant Secretary for Preparedness and Response
Awardee
Cangene Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
AN13 - Health R&D Services; Health Care Services; Experimental Development
Federal Contract Vehicle
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Canada
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Not listed
HHSO100201300009I
Indefinite Delivery Contract
HHSO100201300009I-HHSO10033001T
Delivery Order
Description
Update #1
Posted 9/16/13, 12:00 AM
Name
Description
Solicitation Number
Federal Agency
Type
Posted Date
(Click to sort descending)
Anthrax Antitoxins for the Treatment of Inhalational Anthrax
Added: Jun 15, 2012 3:26 pm The Department of Health and Human Services (HHS) has the responsibility of maintaining a definitive supply of medical countermeasures - or the forward deployment of same - for use in national medical emergencies declared by the Secretary of HHS. HHS has a requirement to acquire, store, and distribute medical countermeasures that will mitigate injuries caused by exposure to chemical, biological teat agents, physical radiologic and nuclear exposures. The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness & Response (ASPR) has a specific need for antax antitoxin products to treat individuals with symptomatic antax disease resulting from aerosol release of Bacillus antacis (B. antacis) spores.
RFP-12-100-SOL-00026
Department of Health and Human Services Immediate Office of the Secretary
Award Notice 1/1
6/15/12, 3:26 PM
Contract Number
Description
Subcontractor
Prime Award
Dollars Obligated
(Click to sort descending)
Updated At
(Click to sort ascending)
PO4500028357S
Storage of AIG Plasma
Life Science Logistics LLC
Delivery Order HHSO100201300009I-HHSO10033001T
$106.4k
1/8/18
PO307049S
Storage of Plasma
Life Science Logistics LLC
Delivery Order HHSO100201300009I-HHSO10033001T
$96.5k
1/12/15
307047S
Collection of human immune plasma for the manufacture of anthrax antitoxins
Biotest Pharmaceuticals Corporation
Delivery Order HHSO100201300009I-HHSO10033001T
$1.0m
1/7/15
306981S
Collection of human immune plasma for the manufacture of anthrax antitoxins.
DCI Management Group, LLC
Delivery Order HHSO100201300009I-HHSO10033001T
$18.1m
1/2/15
PO305732S
Storage of Plasma
Life Science Logistics LLC
Delivery Order HHSO100201300009I-HHSO10033001T
$60.3k
7/31/14
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
1
Other Administrative Action
$0
4/15/14
Not listed
Not listed
$63.3m
9/16/13